Preventing heart damage from chemotherapy in older lymphoma patients
Prevention of Anthracycline Chemotherapy Cardiotoxicity
This study is looking to help older adults with lymphoma by finding ways to prevent heart damage from chemotherapy, figuring out who might be at risk, and understanding what patients and doctors prefer when it comes to treatment options.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11301152 on NIH RePORTER |
What this research studies
This research focuses on preventing serious heart damage caused by anthracycline chemotherapy in older adults diagnosed with lymphoma. It aims to develop better prediction tools to identify patients at risk, analyze current methods of protecting the heart during treatment, and understand the preferences of patients and healthcare providers regarding treatment options. The research will utilize large databases and qualitative methods to gather comprehensive data over a five-year period. By addressing these critical areas, the project seeks to enhance the safety and effectiveness of chemotherapy for older patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults, specifically those aged 65 and above, who are diagnosed with lymphoma and may require anthracycline chemotherapy.
Not a fit: Patients who are younger than 65 or those who do not have lymphoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the risk of heart failure in older adults undergoing chemotherapy for lymphoma.
How similar studies have performed: Previous research has shown promising results in developing cardioprotective strategies for patients undergoing chemotherapy, indicating that this approach has potential for success.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Upshaw, Jenica — Beth Israel Deaconess Medical Center
- Study coordinator: Upshaw, Jenica
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.